Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors-Reference-Cited by-同舟云学术

Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors

Published:2021-01-29 Issue: Volume: Page:1-14
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Islam Rayhanul¹,Maeda Hiroshi²³,Fang Jun¹

Affiliation:

1. Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan

2. BioDynamics Research Foundation, Kumamoto, Japan

3. Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Funder

supported in part by Grants-in-Aid for Scientific Research

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1874916

Reference105 articles.

1. A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy-Problems, Solutions, and Prospects

2. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

3. Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects

4. Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer;European Journal of Pharmacology;2024-10

2. Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09

3. Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy;Journal of Translational Medicine;2024-07-03

4. Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

5. Nanoemulsion based lipid nanoparticles for effective demethylcantharidin delivery to cure liver cancer;Chemical Biology & Drug Design;2024-07